Ares Q1 2026 Results Show Record Fundraising

Ares Q1 2026 results show record $30.0 billion fundraising and revenue growth, signaling robust institutional demand and easing private credit concerns.

May 01, 2026·1 min read
View all news articles
Flat vector of a vault expanding loan modules to symbolize Ares Q1 2026 results and record fundraising strength.

KEY TAKEAWAYS

  • Recorded $30.0 billion in first-quarter fundraising and roughly 45.0% year-over-year growth.
  • Revenue rose to $1.4 billion, while GAAP net income reached $143 million, reflecting improved profitability.
  • U.S. direct lending commitments totaled $9.5 billion in Q1 and $53.0 billion on a trailing 12-month basis.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Ares Management Corporation (ARES) reported stronger revenue and record fundraising in its Q1 2026 results released on May 1, 2026, reflecting robust institutional investor demand and easing recent concerns about the private-credit market.

Quarterly Results and Fundraising

Ares posted GAAP net income of $142.6 million for Q1 2026, a 202% increase from $47.2 million a year earlier, the company said in a press release. Total revenue rose 28% to $1.4 billion from $1.09 billion. Net income per share (basic and diluted) was $0.46, while after-tax realized income reached $452.4 million.

The firm recorded a record first-quarter fundraising total of $30 billion, representing more than 45% year-over-year growth. This surge in capital reflects continued strong institutional appetite for private-credit investments.

Fundraising and Direct Lending Activity

In a separate statement, Ares reported U.S. direct-lending commitments of $9.5 billion across 70 transactions in Q1 2026. Over the trailing 12 months ended March 31, 2026, commitments totaled $53.0 billion across 348 transactions.

The combination of record fundraising and sustained loan origination underscores ongoing institutional demand and Ares’s capacity to deploy capital. The significant after-tax realized income also contributed to the quarter’s profitability, highlighting the role of realized gains in the results.

This mix of fresh capital and realized returns positions Ares to continue underwriting and placing loans as market conditions evolve, reinforcing its role in private-credit markets.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

ExxonMobil Q1 2026 Earnings Beat, Shares Slip

ExxonMobil Q1 2026 Earnings Beat, Shares Slip

ExxonMobil Q1 2026 earnings beat on adjusted measures but GAAP profit fell sharply after Iran disruptions and derivative timing, prompting share weakness.

Berkshire Hathaway Annual Meeting: Abel's Debut

Berkshire Hathaway Annual Meeting: Abel's Debut

Berkshire Hathaway annual meeting will test Greg Abel's debut as CEO and could shift investor sentiment and positioning after Buffett's exit.

Moderna Q1 2026 Results Show Vaccine Sales Lift

Moderna Q1 2026 Results Show Vaccine Sales Lift

Moderna Q1 2026 results showed COVID vaccine sales lifted revenue while a $0.9 billion litigation settlement widened GAAP loss and may shift positioning.

Atlassian Earnings Lift Outlook on AI Push

Atlassian Earnings Lift Outlook on AI Push

Atlassian earnings showed Q3 revenue of $1.8 billion and a raised FY2026 revenue forecast, backing AI-led growth and bolstering investor positioning.

Twilio Earnings and Guidance Lift Stock on AI Demand

Twilio Earnings and Guidance Lift Stock on AI Demand

Twilio earnings beat estimates and management raised full-year revenue-growth guidance on AI-driven demand, lifting after-hours shares and trader flows.

AstraZeneca Camizestrant FDA Panel Rejects Candidate

AstraZeneca Camizestrant FDA Panel Rejects Candidate

AstraZeneca camizestrant FDA panel vote raises regulatory uncertainty and could pressure shares as the company consults U.S. regulators